Latest trials show Pfizer Covid-19 vaccine to be 90% effective – With insights from the Wall Street Journal

Pfizer and its partner BioNTech plan to seek FDA authorisation by the end of November to sell the vaccine, pending safety data.

Pfizer and its partner BioNTech plan to seek FDA authorisation by the end of November to sell the vaccine, pending safety data.

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).